Cells were plated at 1000 cells/well in 96 half-well plates. Serial dilutions of drugs or anti-LGR5 ADC were added and allowed to incubate at 37°C for 3–4 days as indicated. For experiments using Rho inhibitor I or tariquidar, cells were pretreated for approximately 24 hours and 1 hour prior to drug or ADC treatment, respectively. Cell cytotoxicity was measured using CellTiter-Glo (Promega) according to manufacturer’s protocol. Luminescence was measured using EnVision mulitlabel plate reader (PerkinElmer). For proliferation studies, measurements were acquired once a day for 4–5 days (n =3–4 experiments). Each condition was tested in at least triplicates. Cytotoxicity data is shown as a single experiment representative of 3–4 independent experiments.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.